AI Engines For more Details: Perplexity Kagi Labs You
Nutritional Benefits: Beef is a rich source of protein, iron, zinc, and B vitamins such as vitamin B12 and niacin. These nutrients are essential for various bodily functions including muscle growth, immune function, and energy metabolism.
High Saturated Fat Content: Beef, especially fattier cuts, can be high in saturated fat, which has been linked to an increased risk of heart disease when consumed in excess. It's recommended to choose leaner cuts of beef and trim visible fat to reduce saturated fat intake.
Potential for Increased Cholesterol Levels: High consumption of saturated fat, commonly found in beef, can contribute to elevated levels of LDL cholesterol (the "bad" cholesterol) in some individuals, which is a risk factor for cardiovascular disease.
Risk of Colon Cancer: Some studies suggest that high intake of red meat, including beef, may be associated with an increased risk of colorectal cancer. The exact mechanisms are not fully understood, but it's believed that compounds formed during the cooking process, such as heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons (PAHs), may play a role.
Potential Allergen: Beef allergies are relatively uncommon but can occur. Symptoms can range from mild itching and hives to severe reactions such as anaphylaxis.
Impact on Environmental Health: While not a direct health impact on individuals, the production of beef has significant environmental implications, including greenhouse gas emissions, deforestation, and water usage.
Rank | Probiotic | Impact |
---|---|---|
species | Escherichia coli | Increases |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Acne | 0.8 | 0.6 | 0.33 |
ADHD | 0.8 | 0.8 | |
Allergic Rhinitis (Hay Fever) | 0.8 | -0.8 | |
Allergies | 0.8 | 1 | -0.25 |
Allergy to milk products | 1.2 | 0.6 | 1 |
Alopecia (Hair Loss) | 0.6 | -0.6 | |
Alzheimer's disease | 0.8 | 1.4 | -0.75 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 1.4 | 1.6 | -0.14 |
Ankylosing spondylitis | 1 | 2 | -1 |
Anorexia Nervosa | 0.2 | 0.8 | -3 |
Antiphospholipid syndrome (APS) | 0.6 | -0.6 | |
Asthma | 1.2 | 0.6 | 1 |
Atrial fibrillation | 1.2 | 0.6 | 1 |
Autism | 2.4 | 1.8 | 0.33 |
benign prostatic hyperplasia | 0.8 | -0.8 | |
Bipolar Disorder | 0.8 | 1.6 | -1 |
Brain Trauma | 0.8 | -0.8 | |
Carcinoma | 0.8 | -0.8 | |
Celiac Disease | 1.2 | 0.8 | 0.5 |
Chronic Fatigue Syndrome | 0.6 | 0.4 | 0.5 |
Chronic Kidney Disease | 0.6 | 0.8 | -0.33 |
Chronic Lyme | 0.6 | -0.6 | |
Chronic Urticaria (Hives) | 0.8 | -0.8 | |
Coagulation / Micro clot triggering bacteria | 1.8 | -1.8 | |
Colorectal Cancer | 2.2 | -2.2 | |
Constipation | 1.6 | -1.6 | |
COVID-19 | 0.6 | 2.6 | -3.33 |
Crohn's Disease | 1.4 | 2.6 | -0.86 |
cystic fibrosis | 1 | -1 | |
deep vein thrombosis | 1.4 | -1.4 | |
Depression | 1.8 | 2.4 | -0.33 |
Dermatomyositis | 0.6 | 0.6 | |
Eczema | 1.4 | -1.4 | |
Endometriosis | 2.2 | -2.2 | |
Eosinophilic Esophagitis | 0.8 | 0.8 | |
Epilepsy | 0.6 | 1.6 | -1.67 |
Functional constipation / chronic idiopathic constipation | 0.6 | 2.4 | -3 |
gallstone disease (gsd) | 0.8 | -0.8 | |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.6 | -0.6 | |
Generalized anxiety disorder | 1 | -1 | |
Gout | 0.4 | -0.4 | |
Graves' disease | 1.4 | 0.2 | 6 |
Hashimoto's thyroiditis | 0.2 | 0.2 | |
Heart Failure | 0.2 | -0.2 | |
Hidradenitis Suppurativa | 0.6 | 0.6 | |
Histamine Issues,Mast Cell Issue, DAO Insufficiency | 0.6 | -0.6 | |
hyperglycemia | 0.8 | -0.8 | |
Hyperlipidemia (High Blood Fats) | 0.2 | 0.2 | |
hypersomnia | 0.2 | -0.2 | |
hypertension (High Blood Pressure | 0.2 | 1.2 | -5 |
IgA nephropathy (IgAN) | 0.6 | -0.6 | |
Inflammatory Bowel Disease | 0.8 | 2 | -1.5 |
Insomnia | 0.6 | 0.6 | |
Irritable Bowel Syndrome | 1 | 2.2 | -1.2 |
Juvenile idiopathic arthritis | 0.6 | 0.6 | |
Liver Cirrhosis | 1.8 | -1.8 | |
Long COVID | 1.6 | 2.4 | -0.5 |
Lung Cancer | 0.2 | 0.8 | -3 |
Metabolic Syndrome | 1 | 2.8 | -1.8 |
Mood Disorders | 2.6 | 2.8 | -0.08 |
Multiple Sclerosis | 0.6 | 0.2 | 2 |
myasthenia gravis | 0.6 | 0.6 | |
Neuropathy (all types) | 0.6 | 0.6 | 0 |
neuropsychiatric disorders (PANDAS, PANS) | 0.6 | 0.2 | 2 |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 2 | -2 | |
Obesity | 1 | 2.6 | -1.6 |
obsessive-compulsive disorder | 1.8 | -1.8 | |
Osteoarthritis | 0.6 | 0.6 | 0 |
Osteoporosis | 0.6 | 0.8 | -0.33 |
Parkinson's Disease | 1.8 | 1 | 0.8 |
Polycystic ovary syndrome | 1.4 | -1.4 | |
Postural orthostatic tachycardia syndrome | 0.6 | -0.6 | |
Psoriasis | 1.2 | -1.2 | |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.8 | 2 | -1.5 |
Rosacea | 0.8 | 0.8 | |
Schizophrenia | 1.2 | 0.6 | 1 |
Sjögren syndrome | 1.4 | -1.4 | |
Sleep Apnea | 1.4 | -1.4 | |
Small Intestinal Bacterial Overgrowth (SIBO) | 0.6 | 1.2 | -1 |
Stress / posttraumatic stress disorder | 0.6 | 1 | -0.67 |
Systemic Lupus Erythematosus | 0.8 | 2 | -1.5 |
Type 1 Diabetes | 1.2 | -1.2 | |
Type 2 Diabetes | 1.2 | 2.6 | -1.17 |
Ulcerative colitis | 1.4 | 2.8 | -1 |
Unhealthy Ageing | 0.6 | -0.6 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.